Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: Dec. 10, 2024
Immunogenic
cell
death
(ICD)
is
a
distinct
type
of
stress-induced
regulated
that
can
lead
to
adaptive
immune
responses
and
the
establishment
immunological
memory.
ICD
exhibits
both
similarities
differences
when
compared
apoptosis
other
non-apoptotic
forms
(RCD).
The
interplay
between
ICD-mediated
immunosurveillance
against
cancer
ability
cells
evade
influences
host-tumor
interaction.
Consequently,
restoration
development
effective
strategies
induce
have
emerged
as
crucial
considerations
in
treatment
within
context
immunotherapy.
To
enhance
comprehension
setting
cancer,
this
paper
examines
interconnected
responsive
pathways
associated
with
ICD,
corresponding
biomarkers
indicative
mechanisms
through
which
tumors
subvert
ICD.
Additionally,
review
explores
for
reinstating
therapeutic
potential
harnessing
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1023 - 1023
Published: Jan. 13, 2024
Photodynamic
therapy
(PDT)
is
a
two-stage
treatment
that
implies
the
use
of
light
energy,
oxygen,
and
light-activated
compounds
(photosensitizers)
to
elicit
cancerous
precancerous
cell
death
after
activation
(phototoxicity).
The
biophysical,
bioengineering
aspects
its
combinations
with
other
strategies
are
highlighted
in
this
review,
both
conceptually
as
they
currently
applied
clinically.
We
further
explore
recent
advancements
PDT
nanotechnology,
including
quantum
dots
innovative
photosensitizers
or
energy
donors
well
combination
radiotherapy
immunotherapy
future
promising
cancer
treatments.
Finally,
we
emphasize
potential
significance
organoids
physiologically
relevant
models
for
PDT.
ChemMedChem,
Journal Year:
2024,
Volume and Issue:
19(11)
Published: March 6, 2024
Copper
(Cu),
a
crucial
trace
element
in
physiological
processes,
has
garnered
significant
interest
for
its
involvement
cancer
progression
and
potential
therapeutic
applications.
The
regulation
of
cellular
copper
levels
is
essential
maintaining
homeostasis,
as
imbalances
can
lead
to
toxicity
cell
death.
development
drugs
that
target
homeostasis
emerged
promising
strategy
anticancer
treatment,
with
particular
focus
on
chelators,
ionophores,
novel
complexes.
Recent
research
also
investigated
the
complexes
therapy.
Current Issues in Molecular Biology,
Journal Year:
2025,
Volume and Issue:
47(2), P. 69 - 69
Published: Jan. 21, 2025
Photodynamic
therapy
is
a
non-ionizing
radiation
treatment
that
utilizes
photosensitizer
in
combination
with
light
to
produce
singlet
oxygen.
This
oxygen
induces
anti-cancer
effects
by
causing
apoptotic,
necrotic,
or
autophagic
cell
death
tumor
cells.
Currently,
photodynamic
employed
oncology
treat
various
cancers.
In
the
presence
of
oxygen,
this
non-invasive
approach
leads
direct
death,
damage
microvasculature,
and
induction
local
inflammatory
response.
These
allow
be
effective
treating
early-stage
tumors,
extending
survival
cases
where
surgery
not
feasible,
significantly
improving
quality
life.
paper,
we
provide
state
art
on
cytomolecular
mechanisms
associated
pathways
involved
therapy.
By
integrating
these
mechanistic
insights
most
recent
advancements
nanotechnology,
phototherapeutic
has
potential
become
prevalent
option
within
conventional
cancer
therapies,
enhancing
its
application
precision
medicine.
Cell Death Discovery,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Nov. 11, 2024
Cancer
has
emerged
as
a
formidable
challenge
in
the
21st
century,
impacting
society,
public
health,
and
economy.
Conventional
cancer
treatments
often
exhibit
limited
efficacy
considerable
side
effects,
particularly
managing
advanced
stages
of
disease.
Photodynamic
therapy
(PDT),
contemporary
non-invasive
therapeutic
approach,
employs
photosensitizers
(PS)
conjunction
with
precise
light
wavelengths
to
selectively
target
diseased
tissues,
inducing
generation
reactive
oxygen
species
ultimately
leading
cell
apoptosis.
In
contrast
conventional
therapies,
PDT
presents
lower
incidence
effects
greater
precision
targeting.
The
integration
intelligent
nanotechnology
into
markedly
improved
its
effectiveness,
evidenced
by
remarkable
synergistic
antitumor
observed
utilization
multifunctional
nanoplatforms
PDT.
This
paper
provides
concise
overview
principles
underlying
PS
PDT,
while
also
delving
nanomaterial-based
context
treatment.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116845 - 116845
Published: May 28, 2024
Lung
cancer
is
one
of
the
common
forms
that
affects
both
men
and
women
regarded
as
leading
cause
related
deaths.
It
characterized
by
unregulated
cell
division
altered
cells
within
lung
tissues.
Green
nanotechnology
a
promising
therapeutic
option
adopted
in
research.
Dicoma
anomala
(D.
anomala)
commonly
used
African
medicinal
plant
treatment
different
medical
conditions
including
cancer.
In
present
study,
silver
nanoparticles
(AgNPs)
were
synthesized
using
D.
MeOH
root
extract.
We
evaluated
anticancer
efficacy
AgNPs
an
individual
well
combination
with
pheophorbide
(PPBa)
mediated
photodynamic
therapy
(PDT)
vitro.
UV-VIS
spectroscopy,
high-resolution
transmission
electron
microscopy
(HR-TEM),
Scanning
(SEM)
energy
dispersive
X-ray
spectroscopy
(EDS)
was
to
confirm
formation
D.A
AgNPs.
Post
24
h
treatment,
A549
for
ATP
proliferation,
morphological
changes
supported
LIVE/DEAD
assay,
caspase
activities.
All
experiments
repeated
four
times
(n=4),
findings
being
analysed
SPSS
statistical
software
version
27
set
at
0.95
confidence
interval.
The
results
from
study
revealed
dose-dependent
decrease
proliferation
PPBa
PDT
on
significant
changes.
Additionally,
assay
displayed
increase
number
dead
population
treatments
(i.e.,
IC
Journal of drug targeting,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 43
Published: Feb. 19, 2025
In
the
dynamic
arena
of
cancer
therapeutics,
chemoimmunotherapy
has
shown
tremendous
promise,
especially
for
aggressive
forms
breast
like
triple-negative
(TNBC).
This
review
delves
into
significant
role
liposomes
in
enhancing
effectiveness
by
leveraging
cancer-specific
mechanisms
such
as
induction
immunogenic
cell
death
(ICD),
reprogramming
tumor
microenvironment
(TME),
and
enabling
sequential
drug
release.
We
examine
innovative
dual-targeting
that
capitalize
on
heterogeneity,
well
pH-sensitive
formulations
offer
improved
control
over
delivery.
Unlike
prior
analyses,
this
directly
links
advancements
preclinical
research-such
PAMAM
dendrimer-based
nanoplatforms
RGD-decorated
liposomes-to
clinical
trial
results,
highlighting
their
potential
to
revolutionize
TNBC
treatment
strategies.
Additionally,
we
address
ongoing
challenges
related
scalability,
toxicity,
regulatory
compliance,
propose
future
directions
personalized,
immune-focused
nanomedicine.
work
not
only
synthesizes
latest
research
but
also
offers
a
framework
translating
liposomal
from
laboratory
practice.